The impact of intralesional interferon α-2b injection therapy on penile hemodynamics in men with Peyronie's disease

Journal of Sexual Medicine

Volumn 2, Issue 5, 2005, Pages 709-715

  Kendirci, Muammer ^a   Usta, Mustafa F ^a   Matern, Richard V ^a   Nowfar, Sepehr ^a   Sikka, Suresh C ^a   Hellstrom, Wayne J G ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Erectile Dysfunction; Interferon; Intralesional Therapy; Penile Ultrasound; Peyronie's Disease

Indexed keywords

ALPHA2B INTERFERON; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DOPPLER FLOWMETRY; HEMODYNAMICS; HUMAN; MALE; PENILE BLOOD FLOW; PENIS ERECTION; PEYRONIE DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 28544449100     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2005.00110.x     Document Type: Article

References (26)

1. Smith BH. Peyronie's disease. Am J Clin Pathol 1966;45:670-8.
2. Weidner W, Schroeder-Printzen I, Weiske WH, Vosshenrich R. Sexual dysfunction in Peyronie's disease: An analysis of 222 patients without previous local plaque therapy. J Urol 1997;157:325-8.
3. Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie's disease: Results of a large survey. BJU Int 2001;88:727-30.
4. Kadioglu A, Oktar T, Kandirali E, Kendirci M, Sanli O, Ozsoy C. Incidentally diagnosed Peyronie's disease in men presenting with erectile dysfuntion. Int J Impot Res 2004;16:540-3.
5. Gelbard MK, Dorey F, James K. The natural history of Peyronie's disease. J Urol 1990;144:1376-9.
6. Lopez JA, Jarow JP. Penile vascular evaluation of men with Peyronie's disease. J Urol 1993;149:53-5.
7. Montorsi F, Guazzoni G, Bergamaschi F, Consonni P, Rigatti P, Pizzini G, Miani A. Vascular abnormalities in Peyronie's disease: The role of color Doppler sonography. J Urol 1994;151:373-5.
8. Brock G, Kadioglu A, Lue TF. Peyronie's disease: A modified treatment. Urology 1993;42:300-4.
9. Lue TF, Hricak H, Marich KW, Tanagho EA. Vasculogenic impotence evaluated by high-resolution ultrasonography and pulsed Doppler spectrum analysis. Radiology 1985;155:777-81.
10. Hellstrom WJG. Single-blind, multicenter, placebo-controlled, parallel study to assess the safety and efficacy of intralesional alpha-2b in the nonsurgical treatment of Peyronie's disease. J Urol 2003;169(4 suppl):274 (Abstract 1605).
11. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822-30.
12. Lee B, Sikka SC, Randrup ER, Villemarette P, Baum N, Hower JF, Hellstrom WJG. Standardization of penile blood flow parameters in normal men using intracavernous prostaglandin E1 and visual sexual stimulation. J Urol 1993;149:49-52.
13. Wilkins CJ, Sriprasad S, Sidhu PS. Colour Doppler ultrasound of the penis. Clin Radiol 2003;58:514-23.
14. Levine LA. Treatment of Peyronie's disease with intralesional verapamil injection. J Urol 1997; 158:1395-9.
15. Stuart-Harris RC, Lauchlan R, Day R. The clinical application of the interferons: A review. NSW Therapeutic Assessment Group. Med J Aust 1992;156:869-72.
16. Duncan MR, Berman B, Nseyo UO. Regulation of the proliferation and biosynthetic activities of cultured human Peyronie's disease fibroblasts by interferons-alpha, -beta and -gamma. Scand J Urol Nephrol 1991;25:89-94.
17. Benson RC, Knoll LD, Furlow WL. Inteferon alpha-2b in the treatment of Peyronie's disease. J Urol 1991;145:342A.
18. Wegner HE, Andresen R, Knipsel HH, Miller K. Treatment of Peyronie's disease with local interferon alpha-2b. Eur Urol 1995;28:236-40.
19. Wegner HE, Andresen R, Knispel HH, Miller K. Local Interferon alpha-2b is not an effective treatment in early-stage Peyronie's disease. Eur Urol 1997;32:190-3.
20. Brake M, Loertzer H, Horsch R, Keller H. Treatment of Peyronie's disease with local interferon alpha-2b. BJU Int 2001;87:654-7.
21. Judge IS, Wisniewski ZS. Intralesional interferon in the treatment of Peyronie's disease: A pilot study. Br J Urol 1997;79:40-2.
22. Ahuja S, Bivalacqua TJ, Case J, Vincent M, Sikka SC, Hellstrom WJ. A pilot study demonstrating clinical benefit from intralesional interferon alpha-2B in the treatment of Peyronie's disease. J Androl 1999;20:444-8.
23. 3 Kadioglu A, Tefekli A, Erol H, Cayan S, Kandirali E. Color Doppler ultrasound assessment of penile vascular system in men with Peyronie's disease. Int J Impot Res 2000;12:263-7.
24. Usta MF, Bivalacqua TJ, Tokatli Z, Rivera F, Gulkesen KH, Sikka SC, Hellstrom WJG. Stratification of penile vascular pathologies in patients with Peyronie's disease and in men with erectile dysfunction according to age: A comparative study. J Urol 2004;172:259-62.
25. Polat O, Gul O, Ozbey I, Ozdikici M, Bayraktar Y. Peyronie's disease: Intralesional treatment with interferon alpha-2A and evaluation of the results by magnetic resonance imaging. Int Urol Nephrol 1997;29:465-71.
26. Andresen R, Wegner HE, Banzer D, Miller K. Ultrasound and soft-tissue radiography to monitor local interferon alpha-2 B treatment in Peyronie's disease. Acta Radiol 1996;37:352-6.